Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension (2023)
- Authors:
- Autor USP: SOUZA, ROGÉRIO DE - FM
- Unidade: FM
- DOI: 10.1056/NEJMoa2213558
- Subjects: HIPERTENSÃO PULMONAR; PROTEÍNAS RECOMBINANTES; FÁRMACOS (SISTEMA CARDIOVASCULAR); RESULTADO DE TRATAMENTO
- Language: Inglês
- Imprenta:
- Source:
- Título: New england journal of medicine
- ISSN: 0028-4793
- Volume/Número/Paginação/Ano: v. 388, n. 16, p. 1478-1490, 2023
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
HOEPER, Marius M et al. Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension. New england journal of medicine, v. 388, n. 16, p. 1478-1490, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/56025. Acesso em: 09 fev. 2026. -
APA
Hoeper, M. M., Badesch, D. B., Ghofrani, H. A., Gibbs, J. S. R., Gomberg-Maitland, M., Mclaughlin, V. V., et al. (2023). Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension. New england journal of medicine, 388( 16), 1478-1490. doi:10.1056/NEJMoa2213558 -
NLM
Hoeper MM, Badesch DB, Ghofrani HA, Gibbs JSR, Gomberg-Maitland M, Mclaughlin VV, Preston IR, Souza R de, Waxman AB, Grünig E. Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension [Internet]. New england journal of medicine. 2023 ; 388( 16): 1478-1490.[citado 2026 fev. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/56025 -
Vancouver
Hoeper MM, Badesch DB, Ghofrani HA, Gibbs JSR, Gomberg-Maitland M, Mclaughlin VV, Preston IR, Souza R de, Waxman AB, Grünig E. Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension [Internet]. New england journal of medicine. 2023 ; 388( 16): 1478-1490.[citado 2026 fev. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/56025 - Incidência de hematomas subdurais espontâneos em casos de pacientes com hipertensão arterial pulmonar: Análise de um registro de cinco anos
- Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. [Carta]
- Pulmonary hypertension in sickle cell disease
- Challenging the concept of adding more drugs in pulmonary arterial hypertension [Editorial]
- Pulmonary arterialhHypertension-related morbidity is prognostic for mortality
- RV Fractional Area Change and TAPSE as Predictors of Severe Right Ventricular Dysfunction in Pulmonary Hypertension: A CMR Study
- 2016 – Um segundo passo [Editorial]
- Building the Future of Trial Design in PAH on Solid Ground
- Goal-oriented treatment of pulmonary arterial hypertension
- Skeletal Muscle Abnormalities in Pulmonary Arterial Hypertension
Informações sobre o DOI: 10.1056/NEJMoa2213558 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
